Related Experiment Video
Updated: Oct 13, 2026

06:55
Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Heart-lung and bilateral lung transplantation in children with cystic fibrosis
1McGill University, Montreal, Quebec, Canada.
Pediatric Pulmonology. Supplement
|January 1, 1995
Insights
Bilateral lung and heart-lung transplants offer hope for children with cystic fibrosis and end-stage lung disease. This review covers eligibility, surgical methods, and outcomes for these critical procedures.
Area of Science:
- Cardiology
- Pulmonology
- Pediatric Surgery
Background:
- Cystic fibrosis (CF) is a genetic disorder leading to progressive lung damage.
- End-stage lung disease in CF necessitates advanced treatment options.
- Lung and heart-lung transplantation are viable interventions for eligible pediatric patients.
Purpose of the Study:
- To outline the current indications and contraindications for bilateral lung and heart-lung transplantation in pediatric CF patients.
- To describe the surgical techniques employed in these complex transplantations.
- To review the outcomes and results associated with lung and heart-lung transplantation in this population.
Main Methods:
- Review of current literature and clinical guidelines.
- Analysis of patient selection criteria for transplantation.
- Discussion of surgical approaches and post-operative management.
Main Results:
- Established inclusion and exclusion criteria for pediatric CF transplant candidates.
- Detailed description of surgical procedures for lung and heart-lung transplants.
- Summary of patient survival rates and complication profiles.
Conclusions:
- Bilateral lung and heart-lung transplantation are crucial for managing end-stage lung disease in cystic fibrosis.
- Careful patient selection and surgical expertise are paramount for successful outcomes.
- Transplantation offers a significant survival benefit for appropriately selected pediatric CF patients.
Abstract:
Bilateral lung and heart-lung transplantation are indicated for cystic fibrosis children with end-stage lung disease. This article discusses the current criteria for inclusion-exclusion, surgical techniques, and results.

